DanyC submitted, created time 10 months 1 week (www.forbes.com)

There is a $10 billion market for drugs to treat the anemia that occurs after kidney dialysis and cancer chemotherapy. Well, a new study said Amgen and Johnson & Johnson's anti-anemia treatments raise the risk of death via blood clots, and worries coming, that these medicines actually harm patients when overused have caused doctors to limit prescriptions.

Keywords: sickle cell anemia dialysis blood clots cancer drugs anemia anti-anemia drugs